Literature DB >> 30337217

Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insulin resistance.

Reza Fadaei1, Nariman Moradi2, Tooba Kazemi3, Elham Chamani4, Nahid Azdaki3, Sayed Ali Moezibady3, Shiva Shahmohamadnejad5, Soudabeh Fallah6.   

Abstract

Coronary artery disease (CAD) is the leading cause of death worldwide. Atherosclerosis as the main underlying mechanism of CAD is associated with inflammation and adipose tissue dysfunction. C1q/TNF-related protein12 (CTRP12) is a newly discovered adipokine which is a paralog of adiponectin. CTRP12 has anti-inflammatory and insulin sensitizing effects. Circulating levels of this adipokine have been reported to be lower in patients with type 2 diabetes and women with polycystic ovarian syndrome. The present study was undertaken for the first time to evaluate serum levels of CTRP12 in CAD patients and its association with anthropometric and biochemical parameters. Serum levels of CTRP12 were measured using ELISA kit in 188 CAD patients (angiography confirmed) and 70 controls. The serum levels of adiponectin, TNF-α and IL-6 were measured using ELISA kits. Serum levels of CTRP12 were found to be lower in CAD patients (585.48 ± 201.67 pg/mL) than in the controls (814.86 ± 247.85 pg/mL; p < 0.001). CTRP12 also showed an independent association with the risk of CAD (OR [CI] = 0.998 [0.996-0.999]; p = 0.019). Moreover, it showed an inverse correlation with HOMA-IR (r = -0.298; p = 0.012) and TNF-α (r = -0.269; p = 0.023) and a positive correlation with adiponectin (r = 0.344; p = 0.003) in the controls. In CAD patients, CTRP12 was inversely correlated with BMI (r = -0.181, p = 0.013), HOMA-IR (r = -0.199; p = 0.006), TNF-α (r = -0.259; p < 0.001) and IL-6 (r = -320; p < 0.001) and a positive correlation with high density lipoprotein-cholesterol(r = 0.342; p < 0.001) and adiponectin (r = 0.398; p < 0.001). The present study showed for the first time that serum levels of CTRP12 are independently associated with CAD and that CTRP12 is associated with several CAD risk factors. The results suggest a possible link between CTRP12 and pathogenic mechanisms of atherosclerosis, such as inflammation and high density lipoprotein-cholesterol metabolism; however, more study is required in this regard.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adiponectin; C1q/TNF-related protein 12/adipolin; Cardiovascular disease; Inflammatory cytokines; Insulin resistance

Mesh:

Substances:

Year:  2018        PMID: 30337217     DOI: 10.1016/j.cyto.2018.09.019

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  13 in total

1.  CTRP12 ablation differentially affects energy expenditure, body weight, and insulin sensitivity in male and female mice.

Authors:  Stefanie Y Tan; Xia Lei; Hannah C Little; Susana Rodriguez; Dylan C Sarver; Xi Cao; G William Wong
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-18       Impact factor: 4.310

2.  CTRP12 inhibits triglyceride synthesis and export in hepatocytes by suppressing HNF-4α and DGAT2 expression.

Authors:  Stefanie Y Tan; Hannah C Little; Dylan C Sarver; Paul A Watkins; G William Wong
Journal:  FEBS Lett       Date:  2020-08-14       Impact factor: 4.124

3.  Genetic determinants of metabolic biomarkers and their associations with cardiometabolic traits in Hispanic/Latino adolescents.

Authors:  Daeeun Kim; Anne E Justice; Geetha Chittoor; Estela Blanco; Raquel Burrows; Mariaelisa Graff; Annie Green Howard; Yujie Wang; Rebecca Rohde; Victoria L Buchanan; V Saroja Voruganti; Marcio Almeida; Juan Peralta; Donna M Lehman; Joanne E Curran; Anthony G Comuzzie; Ravindranath Duggirala; John Blangero; Cecilia Albala; José L Santos; Bárbara Angel; Betsy Lozoff; Sheila Gahagan; Kari E North
Journal:  Pediatr Res       Date:  2021-10-13       Impact factor: 3.953

4.  Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function.

Authors:  Nariman Moradi; Reza Fadaei; Mohammad Ebrahim Khamseh; Ali Nobakht; Mohammad Jafar Rezaei; Fereshteh Aliakbary; Akram Vatannejad; Jalil Hosseini
Journal:  PLoS One       Date:  2019-04-22       Impact factor: 3.240

Review 5.  Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases.

Authors:  Ibrahim AlZaim; Safaa H Hammoud; Houssam Al-Koussa; Alaa Ghazi; Ali H Eid; Ahmed F El-Yazbi
Journal:  Front Cardiovasc Med       Date:  2020-11-17

6.  Adipolin/C1q/Tnf-related protein 12 prevents adverse cardiac remodeling after myocardial infarction.

Authors:  Tomonobu Takikawa; Koji Ohashi; Hayato Ogawa; Naoya Otaka; Hiroshi Kawanishi; Lixin Fang; Yuta Ozaki; Shunsuke Eguchi; Minako Tatsumi; Mikito Takefuji; Toyoaki Murohara; Noriyuki Ouchi
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

7.  Exploring the Therapeutic Mechanisms of Huzhang-Shanzha Herb Pair against Coronary Heart Disease by Network Pharmacology and Molecular Docking.

Authors:  Dan Li; Longtao Liu; Shengjie Yang; Yanwei Xing; Limin Pan; Ran Zhao; Yixi Zhao; Guirui Huang; Min Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-30       Impact factor: 2.629

Review 8.  A Review of the Relationship Between CTRP Family and Coronary Artery Disease.

Authors:  Yueqiao Si; Wenjun Fan; Lixian Sun
Journal:  Curr Atheroscler Rep       Date:  2020-05-28       Impact factor: 5.113

9.  CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway.

Authors:  Gang Wang; Jiao-Jiao Chen; Wen-Yi Deng; Kun Ren; Shan-Hui Yin; Xiao-Hua Yu
Journal:  Cell Death Dis       Date:  2021-03-10       Impact factor: 8.469

Review 10.  The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin.

Authors:  Han Na Jung; Chang Hee Jung
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.